Mendelian randomization for nephrologists
Kidney International · 2023-12 · 104 (6) · 1113-1123
DOI: 10.1016/j.kint.2023.09.016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney International, 2023-12. Verfasst von Ellen Dobrijevic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Centre for Kidney Resea…. Hauptthemen laut MEDLINE: Nephrologists, Nephrology. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Confounding is a major limitation of observational studies. Mendelian randomization (MR) is a powerful study design that uses genetic variants as instrumental variables to enable examination of the causal effect of an exposure on an outcome in observational data. With the emergence of large-scale genome-wide association studies in nephrology over the past decade, MR has become a popular method to establish causal inferences. However, MR is a complex and challenging methodology that requires careful consideration to ensure robust results. This review article aims to summarize the basic concepts of MR, its application and relevance in nephrology, and the methodological challenges and limitations as well as discuss the current guidelines for design and reporting. With reference to a clinically relevant example of examining the causal relationship between the estimated glomerular filtration rate and cancer, this review outlines the key steps to conducting an MR study, including the key considerations and potential pitfalls at each step. These include defining the clinical question, selecting the data sources, identifying and refining appropriate genetic variants by considering linkage disequilibrium and associations with potential confounders, harmonization of variants across data sets, validation of the genetic instrument by assessing its strength, estimation of the causal effects, confirming the validity of the findings, and interpreting and reporting results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Centre for Kidney Research, Kids Research Institute, The Children's Hospital at Westmead, Wes…
- Division of Nephrology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
- Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Dobrijevic, E., van Zwieten, A., Kiryluk, K., Grant, A. J., Wong, G., & Teixeira-Pinto, A. (2023). Mendelian randomization for nephrologists. Kidney International, 104(6), 1113-1123. https://doi.org/10.1016/j.kint.2023.09.016
Vancouver
Dobrijevic E, van Zwieten A, Kiryluk K, Grant AJ, Wong G, Teixeira-Pinto A. Mendelian randomization for nephrologists. Kidney International. 2023;104(6):1113-1123. doi:10.1016/j.kint.2023.09.016
BibTeX
@article{Dobrijevic2023,
author = {Dobrijevic, Ellen and van Zwieten, Anita and Kiryluk, Krzysztof and Grant, Andrew J and Wong, Germaine and Teixeira-Pinto, Armando},
title = {Mendelian randomization for nephrologists},
journal = {Kidney International},
year = {2023},
volume = {104},
number = {6},
pages = {1113--1123},
doi = {10.1016/j.kint.2023.09.016}
}
EUVIMED